Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Dr. Vince Clinical Research

News headline image
Dr. Vince Clinical Research Expands CRO Capabilities as William Lavery, MD, PhD, Earns Board Certification in Obesity Medicine
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Expands Leadership in Renal and Hepatic Clinical Pharmacology Studies
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Announces First Dosing in Atopic Dermatitis Patients with Enveda’s First-in-Class Investigational Drug ENV-294
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Campus Expansion Marks Dr. Vince Clinical Research’s Investment in People, Infrastructure and Innovation
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Expands Campus with New Administration Building
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Builds Clinical Laboratory Division
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Appoints World-Renowned Drug Developer, Clinical Pharmacologist and Neuroscientist Dr. Sheldon Preskorn as Senior VP of Neuroscience
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients With Depression
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Launches New Solution for Organ Impairment Studies
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Announces First Dosing in Cingulate Therapeutics’ CTx-1301 Phase III Laboratory Classroom Study in ADHD Patients
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research, Clario Form Strategic Partnership to Deliver Innovative Cardiac Assessments in Clinical Trials
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Joins the Fight Against the Fentanyl Crisis, Announces Screening of First Subject for Cessation Therapeutics’ Overdose Prevention Therapy in a First-In-Human Trial
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Now Green Certified
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Announces Dosing of Aclaris Therapeutics’ Phase I MAD Study of ATI-2138
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Strengthens Investigator Team with the Addition of George Atiee, MD
From Dr. Vince Clinical Research
Via GlobeNewswire
News headline image
Dr. Vince Clinical Research Announces Dosing of Ensysce’s PF614 Compound in Human Abuse Potential Trial
From Dr. Vince Clinical Research
Via GlobeNewswire
News headline image
Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit
From Dr. Vince Clinical Research
Via Business Wire
News headline image
WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research
From Dr. Vince Clinical Research
Via Business Wire
News headline image
Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience
From Dr. Vince Clinical Research
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.